Vyome Inc. (HIND)
NASDAQ: HIND
· Real-Time Price · USD
5.36
0.19 (3.68%)
At close: Sep 29, 2025, 3:59 PM
5.28
-1.40%
After-hours: Sep 29, 2025, 07:47 PM EDT
3.68% (1D)
| Bid | 5.27 |
| Market Cap | 141.2M |
| Revenue (ttm) | 6.45M |
| Net Income (ttm) | -4.5M |
| EPS (ttm) | -0.05 |
| PE Ratio (ttm) | -107.1 |
| Forward PE | n/a |
| Analyst | n/a |
| Dividends | n/a |
| Ask | 5.53 |
| Volume | 347,925 |
| Avg. Volume (20D) | 551,294 |
| Open | 5.65 |
| Previous Close | 5.17 |
| Day's Range | 5.20 - 5.80 |
| 52-Week Range | 5.04 - 720.00 |
| Beta | 1.03 |
| Ex-Dividend Date | n/a |
About HIND
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol HIND
Website n/a
1 week ago
+4.46%
Vyome Holdings shares are trading higher after the...
Unlock content with
Pro Subscription
1 month ago
+21.91%
Vyome Holdings shares are trading higher after the company signed an MoU with Embryyo Technologies to jointly pursue the l AI-enabled medical device market.
1 month ago · businesswire.com
Vyome To Mark First Day of Trading as HIND with Nasdaq Opening BellCAMBRIDGE, Mass.--(BUSINESS WIRE)---- $HIND--Vyome Holdings (Nasdaq: HIND), a clinical-stage healthcare holding company targeting immuno-inflammatory and rare diseases in the US and global markets wit...
1 month ago · businesswire.com
Vyome closes Merger Transaction, Will Trade on Nasdaq as HIND TomorrowCAMBRIDGE, Mass.--(BUSINESS WIRE)---- $HIND--Vyome Therapeutics, Inc. (“Vyome”), a clinical-stage healthcare company targeting immuno-inflammatory and rare diseases in the US and global markets with l...
